Humacyte HUMA
NASDAQ HUMA
$0.57 -0.01 (-1.35%)
As of: Sep 10, 2026 · 2:54 PM EDT

Humacyte (HUMA) Treasury Shares (2020 - 2021)

Humacyte's (HUMA) quarterly Treasury Shares came in at $69.6 million in Q2 2021, little changed quarter-over-quarter from $69.6 million in Q1 2021.

Analysis

Humacyte (HUMA) Treasury Shares (2020 - 2021) Analysis & Trends

Humacyte (HUMA) has reported Treasury Shares for 2 consecutive years, with $69.6 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Treasury Shares changed N/A year-over-year to $69.6 million in Q2 2021; TTM through Jun 2021 was $69.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $69.6 million, changed N/A from the prior year.
  • Treasury Shares was $69.6 million for Q2 2021 at Humacyte, roughly flat from $69.6 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $69.6 million in Q3 2020 and troughed at $69.6 million in Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Krystal Biotech 10.21 Bn 9.36 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - 17.69 Mn
3 Iovance Biotherapeutics 3.64 Bn 3.35 Bn 55.72 Mn -
4 Legend Biotech 3.54 Bn 2.58 Bn 251.50 Mn -
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn -
6 Beam Therapeutics 2.53 Bn 2.53 Bn - -
7 Precigen 2.40 Bn 2.40 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.15 Bn 1.36 Bn 251.87 Mn 655,642.00
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Humacyte 133.67 Mn 133.67 Mn -825,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 69.61 Mn
Jun 30, 2021 69.61 Mn
Mar 31, 2021 69.61 Mn
Mar 31, 2021 69.61 Mn
Dec 31, 2020 69.61 Mn
Dec 31, 2020 69.61 Mn
Sep 30, 2020 69.61 Mn
Sep 30, 2020 69.61 Mn